Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078071 | SCV000109909 | pathogenic | not provided | 2018-01-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000022028 | SCV000630332 | pathogenic | Biotinidase deficiency | 2024-01-19 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 543 of the BTD protein (p.Asp543Glu). This variant is present in population databases (rs146136265, gnomAD 0.06%). This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 25174816, 25967232, 28498829). ClinVar contains an entry for this variant (Variation ID: 25103). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000078071 | SCV000888013 | pathogenic | not provided | 2018-08-24 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000022028 | SCV001136351 | pathogenic | Biotinidase deficiency | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000022028 | SCV003835260 | pathogenic | Biotinidase deficiency | 2024-03-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000078071 | SCV004039642 | likely pathogenic | not provided | 2024-07-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as D543E; This variant is associated with the following publications: (PMID: 26810761, 25174816, 25967232, 22698809, 28498829, 35167647, 31801038) |
Laboratorio de Genetica e Diagnostico Molecular, |
RCV000022028 | SCV004183396 | likely pathogenic | Biotinidase deficiency | 2020-03-03 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PS4, PM2, PM3, PP2 |
Counsyl | RCV000022028 | SCV000798766 | likely pathogenic | Biotinidase deficiency | 2018-03-30 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000022028 | SCV001461231 | pathogenic | Biotinidase deficiency | 2020-09-16 | no assertion criteria provided | clinical testing |